Apex Trader Funding is a US-based, futures-focused funded-trading firm that uses a monthly-subscription evaluation model. Its founding year was not confirmed in our research, so we leave it unstated rather than guess. The recurring subscription structure has its own cost and risk profile worth understanding before you sign up. We have not completed a hands-on evaluation, so we publish no account sizes, profit split, fees, payout figures or rating until verified on the firm's own site (reviewed June 2026).
Who runs Apex Trader Funding, and is it regulated?
Apex Trader Funding is based in the United States and is futures-focused. We could not confirm its founding year against a primary source, so we do not state one — a deliberate honest gap rather than a guess. US oversight of the funded-account model runs on registration law via the CFTC and NFA, and the funded-account product itself is not a licensed financial product. A US base is a verifiable fact; it is not a regulatory badge.
Because it evaluates traders on exchange-traded futures rather than CFDs, Apex sits in the part of the market less affected by the 2024 MetaQuotes platform withdrawal that hit CFD firms' US access — the same structural point that distinguishes Topstep.
The subscription model: a different cost structure
Apex uses a monthly-subscription evaluation model rather than a one-time challenge fee. This matters in two ways. For the trader, costs recur until you cancel or get funded, so the true cost of a long evaluation can exceed a one-off fee — budget for that and cancel promptly if you stop. For the firm, a subscription implies recurring revenue (and, where an affiliate programme exists, potentially recurring commission), which can shape incentives. Neither is inherently good or bad; both are facts to weigh.
As with any prop firm, a subscription does not make the product regulated or protected. The recurring fee is money at risk, not an investment.
Payout mechanics: read these before you pay
We do not publish Apex Trader Funding's account sizes, profit split, fees or payout frequency. With a subscription model, pay particular attention to how the recurring fee interacts with the rules that can void a payout — consistency requirements, trailing-drawdown limits, minimum trading days and payout minimums. Read these in full on the firm's own site before committing.
An evaluation fee, recurring or not, is at risk and is not an investment. Commit only what you can afford to lose.
Pros & cons
Pros
- Futures-focused (exchange-traded), so less exposed to the MetaQuotes CFD platform withdrawal.
- Verifiable US base.
Cons
- Subscription model means costs recur — the true cost of a long evaluation can exceed a one-off fee.
- Founding year not verifiable, so we do not state one.
- The funded-account product is not a licensed financial product; the recurring fee is money at risk.
Frequently asked questions
How does Apex Trader Funding's subscription work?
Apex uses a monthly-subscription evaluation model rather than a one-time challenge fee, so costs recur until you cancel or get funded. Budget for the recurring cost and cancel promptly if you stop. Confirm the exact current pricing and cancellation terms on the firm's own site — we publish no figure until verified.
Is Apex Trader Funding regulated?
Apex is US-based and futures-focused, but the funded-account product is not a licensed or regulated financial product. US oversight runs on registration law via the CFTC and NFA, not a prop-firm licence. The recurring fee is money at risk with no compensation scheme; read the full rules before paying.